Get more information about the market: https://www.imarcgroup.com/hormone-replacement-therapy-market
The global hormone replacement therapy market reached a value of around US$ 4.2 Billion in 2018. Looking forward, the market is projected to reach a value of US$ 6.3 Billion by 2024, projecting a CAGR of 7% during 2019-2024.
Want more information about this market? Request a free report sample: https://www.imarcgroup.com/hormone-replacement-therapy-market/requestsample
For India market research reports, visit: http://www.marketresearchindia.co.in
Browse Related Report
Wound Care Biologics Market Report: https://www.imarcgroup.com/wound-care-biologics-market
Glioblastoma Multiforme Treatment Market Report: https://www.imarcgroup.com/glioblastoma-multiforme-treatment-market
Contact Us
IMARC Group
James Smith
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 | https://www.imarcgroup.com
Americas :- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331
Linkedin: https://www.linkedin.com/company/imarc-group
2. Report DescriptionAbout IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.
3. Report DescriptionReport Description and Highlights
Global Hormone Replacement Therapy Market Overview:
The latest report by IMARC Group, titled “Hormone Replacement Therapy Market: Global Industry
Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, estimated that the global
hormone replacement therapy market reached a value of around US$ 4.2 Billion in 2018. Hormone
replacement therapy refers to a type of treatment which involves the management of low levels of
hormones, resulting from lack of secretion in the human body. It is suitable for elderly patients
suffering from hypogonadism, women in menopausal transition and patients with deficiency of growth
hormone. HRT is considered to be a more efficacious treatment in comparison to its alternatives such
as chemical drugs, herbal medicines, etc. However, there are some harmful effects of HRT such as
indigestion, nausea, fluid retention, swelling etc. Prolonged consumption of HRT drugs may also
increase the risk of blood clots.
Hormone Replacement Therapy Market Trends
A rise in the prevalence of hormonal imbalance disorders in neonatal as well as elderly population is
the major growth-inducing factor for the market. Apart from this, HRT is considered to be effective in
treating the symptoms of menopause like night sweats, vaginal dryness, hot flashes and sexual
function.
4. Report DescriptionReport Description and Highlights
120.2
125.5 130.8 136.1 141.4 146.7 152.0 157.3
0
20
40
60
80
100
120
140
160
2011 2012 2013 2014 2015 2016 2017 2018
inBillionUS$
160.0 165.3 170.6 175.9 181.2 186.5
0
20
40
60
80
100
120
140
160
180
2019 2020 2021 2022 2023 2024
InBillionUS$
Further, advancements in technology, such as the introduction of transdermal drug delivery and new
gel-based formulations, along with an increasing awareness among the consumers, direct selling
campaigns by the players, population aging and sedentary lifestyles are some of the other drivers
boosting the demand for hormone replacement therapy. Looking forward, the market is projected to
reach a value of US$ 6.3 Billion by 2024, projecting a CAGR of 7% during 2019-2024.
Request for a free sample report: https://www.imarcgroup.com/hormone-replacement-therapy-
market/requestsample
5. Report DescriptionReport Description and Highlights
Moreover, HRT helps in improving the quality of life and minimizes the risk of cardiovascular diseases,
colorectal cancer, vasomotor symptoms and osteoporosis.
For more information, click here: https://www.imarcgroup.com/hormone-replacement-therapy-
market
Key Market Segmentation:
Market Segmentation by Product Type
• Estrogen Replacement Therapy
• Human Growth Hormone Replacement Therapy
• Thyroid Replacement Therapy
• Testosterone Replacement Therapy
• Others
The market has been segregated on the basis of product type into estrogen replacement therapy,
human growth hormone replacement therapy, thyroid replacement therapy and testosterone
replacement therapy. Amongst these, estrogen replacement therapy holds the largest market share.
6. Report Description
Report Description and Highlights
Market Segmentation by Administration
• Oral
• Parenteral
• Transdermal
Based on the route of administration, parenteral represents the leading segment, accounting for the
majority of the market share. It is followed by oral and transdermal methods.
Market Segmentation by Type of Disease
• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Others
On the basis of disease, the report has divided the market into hypothyroidism, menopause, male
hypogonadism and growth hormone deficiency. Currently, menopause accounts for the largest share.
7. Report DescriptionReport Description and Highlights
Market Segmentation by Region
• Asia Pacific
• Europe
• North America
• Middle East and Africa
• Latin America
Regio-wise, North America represents the biggest market for hormone replacement therapy. It is
followed by Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players.
• Abbott
• Bayer AG
• Eli Lilly & Company
8. Report DescriptionReport Description and Highlights
• Roche
• Hisamitsu Pharmaceutical Co. Inc.
• Merck
• Mylan NV
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc
Browse Related Report
Healthcare IT Market Report: https://www.imarcgroup.com/healthcare-it-market
H1N1 Vaccines Market Report: https://www.imarcgroup.com/h1n1-vaccines-market
9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients
10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients